| GO | Name | 
	
		| GO:0001934  | positive regulation of protein phosphorylation | 
	
		| GO:0001963  | synaptic transmission, dopaminergic | 
	
		| GO:0002862  | negative regulation of inflammatory response to antigenic stimulus | 
	
		| GO:0003085  | negative regulation of systemic arterial blood pressure | 
	
		| GO:0005102  | signaling receptor binding | 
	
		| GO:0005179  | hormone activity | 
	
		| GO:0005184  | neuropeptide hormone activity | 
	
		| GO:0005576  | extracellular region | 
	
		| GO:0005615  | extracellular space | 
	
		| GO:0005737  | cytoplasm | 
	
		| GO:0006954  | inflammatory response | 
	
		| GO:0007165  | signal transduction | 
	
		| GO:0007186  | G protein-coupled receptor signaling pathway | 
	
		| GO:0007268  | chemical synaptic transmission | 
	
		| GO:0007565  | female pregnancy | 
	
		| GO:0007567  | parturition | 
	
		| GO:0007611  | learning or memory | 
	
		| GO:0008202  | steroid metabolic process | 
	
		| GO:0008284  | positive regulation of cell population proliferation | 
	
		| GO:0008306  | associative learning | 
	
		| GO:0008628  | hormone-mediated apoptotic signaling pathway | 
	
		| GO:0010628  | positive regulation of gene expression | 
	
		| GO:0010629  | negative regulation of gene expression | 
	
		| GO:0010700  | negative regulation of norepinephrine secretion | 
	
		| GO:0010841  | positive regulation of circadian sleep/wake cycle, wakefulness | 
	
		| GO:0010942  | positive regulation of cell death | 
	
		| GO:0014062  | regulation of serotonin secretion | 
	
		| GO:0016101  | diterpenoid metabolic process | 
	
		| GO:0017045  | corticotropin-releasing hormone activity | 
	
		| GO:0021854  | hypothalamus development | 
	
		| GO:0032811  | negative regulation of epinephrine secretion | 
	
		| GO:0033685  | negative regulation of luteinizing hormone secretion | 
	
		| GO:0035774  | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 
	
		| GO:0035902  | response to immobilization stress | 
	
		| GO:0042322  | negative regulation of circadian sleep/wake cycle, REM sleep | 
	
		| GO:0042493  | response to drug | 
	
		| GO:0043196  | varicosity | 
	
		| GO:0043204  | perikaryon | 
	
		| GO:0043627  | response to estrogen | 
	
		| GO:0043950  | positive regulation of cAMP-mediated signaling | 
	
		| GO:0045202  | synapse | 
	
		| GO:0045471  | response to ethanol | 
	
		| GO:0045472  | response to ether | 
	
		| GO:0048265  | response to pain | 
	
		| GO:0050801  | ion homeostasis | 
	
		| GO:0051412  | response to corticosterone | 
	
		| GO:0051430  | corticotropin-releasing hormone receptor 1 binding | 
	
		| GO:0051431  | corticotropin-releasing hormone receptor 2 binding | 
	
		| GO:0051461  | positive regulation of corticotropin secretion | 
	
		| GO:0051464  | positive regulation of cortisol secretion | 
	
		| GO:0060291  | long-term synaptic potentiation | 
	
		| GO:0060456  | positive regulation of digestive system process | 
	
		| GO:0060548  | negative regulation of cell death | 
	
		| GO:0070093  | negative regulation of glucagon secretion | 
	
		| GO:0071314  | cellular response to cocaine | 
	
		| GO:0071549  | cellular response to dexamethasone stimulus | 
	
		| GO:0090280  | positive regulation of calcium ion import | 
	
		| GO:2000310  | regulation of NMDA receptor activity | 
	
		| GO:2000854  | positive regulation of corticosterone secretion | 
	
		| GO:2000987  | positive regulation of behavioral fear response |